Product Information

PROPAFENONE HCL ER 325 MG CAP is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.5300 per EA under NDC 69680013160. Its NADAC has been published 392 times since Feb 20, 2019.

FDA first approved this application on Jan 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PROPAFENONE HCL ER 325 MG CAP

propafenone
$0.5300per EA

Strength

325 mg/1

NDC

69680013160

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PROPAFENONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210339

FDA Approved

1/4/2019

TE Code

AB

On Market Since

1/28/2019

Pharmacological Classes

Price Statistics

The NADAC for PROPAFENONE HCL ER 325 MG CAP has been published 392 times since Feb 20, 2019, and over the history we have for it it has declined 85.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5300 per EA
All-time high$4.5892 (Apr 15, 2020)
All-time low$0.4264 (Feb 18, 2026)
52-week high$0.7614
52-week low$0.4264
Median price$1.2777
Average price$1.7410
Largest weekly change+97.6% (Oct 20, 2021)
Weeks tracked392
Tracking sinceFeb 20, 2019

Price History

1W

+7.7%

1M

+7.7%

3M

+13.7%

6M

+24.3%

1Y

-30.4%

3Y

-54.6%

5Y

-76.2%

All

-85.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the propafenone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PROPAFENONE HCL ER 325 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL ER 325 MG CAP, manufactured by Vitruvias Therapeutics Inc., is $0.5300 per EA (NDC 69680013160), effective Aug 19, 2026.

How has the price of PROPAFENONE HCL ER 325 MG CAP changed over time?

Over the history we have for it, the NADAC for PROPAFENONE HCL ER 325 MG CAP has declined 85.3%. It has been tracked across 392 weekly CMS publications since Feb 20, 2019.

What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL ER 325 MG CAP?

Since Feb 20, 2019, the NADAC for PROPAFENONE HCL ER 325 MG CAP has ranged from a low of $0.4264 (Feb 18, 2026) to a high of $4.5892 (Apr 15, 2020), with a median of $1.2777 per EA.

Are there cheaper alternatives to PROPAFENONE HCL ER 325 MG CAP?

No other NADAC-published product currently shares the active ingredient and strength of PROPAFENONE HCL ER 325 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PROPAFENONE HCL ER 325 MG CAP?

PROPAFENONE HCL ER 325 MG CAP (NDC 69680013160) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.